Mezzion Pharma (140410.KQ) Earnings Analysis
Mezzion Pharma (140410.KQ) has no confirmed upcoming earnings date. Trailing P/E -43.30.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 140410.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 140410.KQ. This page updates as the calendar is published.
140410.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-16 | -811.51 KRW | n/a | n/a | n/a |
| 2025-11-12 | -171 KRW | n/a | n/a | n/a |
| 2025-05-15 | -111.2865 KRW | n/a | n/a | n/a |
| 2025-03-17 | -390.12393 KRW | n/a | n/a | n/a |
| 2024-11-14 | -213 KRW | n/a | n/a | n/a |
140410.KQ valuation and analyst view
| Trailing P/E | -43.30 |
|---|---|
| Trailing EPS | -1,215.2514 KRW |
| Price / book | 103.44 |
| Dividend yield | 0.00% |
| Market cap | 1559.12B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Mezzion Pharma (140410.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 140410.KQ. This page updates as the calendar is published.
Did 140410.KQ beat earnings last quarter?
Consensus estimate data was not available for 140410.KQ's 2026-03-16 report.
What is 140410.KQ's current P/E ratio and EPS?
140410.KQ trades at a trailing P/E of -43.30 on trailing EPS of -1215.2514039946466 KRW.
What do analysts rate 140410.KQ?
140410.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.